Cite
HARVARD Citation
Bethea, E. et al. (2019). Pre-emptive pangenotypic direct acting antiviral therapy in donor HCV-positive to recipient HCV-negative heart transplantation: an open-label study. Lancet gastroenterology and hepatology. pp. 771-780. [Online].